Hypoalbuminemia is the result of the combined effects of inflammation and inadequate protein and caloric intake in patients with chronic disease such as chronic renal failure. Inflammation and malnutrition both reduce albumin concentration by decreasing its rate of synthesis, while inflammation alone is associated with a greater fractional catabolic rate (FCR) and, when extreme, increased…
Seminars in Dialysis Template
Write in a clean editor, then format for Seminars in Dialysis in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Seminars in Dialysis format
Seminars in Dialysis is a peer-reviewed journal published by Wiley, covering Dialysis and Renal Disease Management, Central Venous Catheters and Hemodialysis, Acute Kidney Injury Research.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Seminars in Dialysis 12 (3): 45–58.
Formats any DOI in Seminars in Dialysis style. No sign-up. |
| Publishes research in | Dialysis and Renal Disease Management Central Venous Catheters and Hemodialysis Acute Kidney Injury Research Vascular Procedures and Complications Muscle and Compartmental Disorders |
| ISSN | 0894-0959 |
| Citation impact (2-yr) | 0.92 |
| h-index | 105 |
| i10-index | 1,681 |
| Total citations | 74,865 |
| Article processing charge | $3,550 |
| Top institutions publishing here | Yale University |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Seminars in Dialysis per year
Citation impact of Seminars in Dialysis by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Seminars in Dialysis
In December 2002, all U.S. chronic hemodialysis centers were surveyed regarding selected patient care practices and dialysis-associated diseases. The results were compared with similar surveys conducted in previous years. In 2002, 85% of hemodialysis centers were free-standing and 81% operated for profit; the proportion of centers operating for profit has increased each year since 1985.…
Cardiovascular disease (CVD) remains the main cause of morbidity and mortality in patients with end-stage renal disease (ESRD). Although traditional risk factors are common in ESRD patients, they alone may not be sufficient to account for the high prevalence of CVD in this condition. Recent evidence demonstrates that chronic inflammation, a nontraditional risk factor which…
Patients with end-stage renal disease (ESRD) develop hemostatic disorders mainly in the form of bleeding diatheses. Hemorrhage can occur at cutaneous, mucosal, or serosal sites. Retroperitoneal or intracranial hemorrhages also occur. Platelet dysfunction is the main factor responsible for hemorrhagic tendencies in advanced kidney disease. Anemia, dialysis, the accumulation of medications due to poor clearance,…
The first reports connecting uremic inflammation with a wasted and atherogenic phenotype and poor outcome initiated in the late 1990s. Since then, about 3500 publications appear on Medline, reflecting the exponential interest that this topic has evoked in nephrology. What was described as a "novel" risk factor 10 years ago has now evolved into an…